Results 161 to 170 of about 5,696 (226)

Genomic landscape of pediatric germ cell tumors reveals oncogenic mutations and copy number alterations. [PDF]

open access: yesFront Oncol
Galvão JMS   +9 more
europepmc   +1 more source

Ovarian Tumor Biomarkers: Correlation Between Tumor Type and Marker Expression, and Their Role in Guiding Therapeutic Strategies. [PDF]

open access: yesInt J Mol Sci
Gawełczyk W   +6 more
europepmc   +1 more source

Navigating Ambiguous Genitalia: A Case of Dysgerminoma in an Afghan Boy. [PDF]

open access: yesInt Med Case Rep J
Haidary M   +5 more
europepmc   +1 more source

Case Report: Activated PI3-kinase-δ syndrome and ovarian malignancies: a case series from the European ESID-APDS registry. [PDF]

open access: yesFront Immunol
Esposto MP   +12 more
europepmc   +1 more source

Dysgerminoma of the ovary

Minerva Obstetrics and Gynecology
Dysgerminoma is a histologic subtype of malignant ovarian germ cell tumor (MOGCT). Most publications describing dysgerminoma are of small cohorts. Large cohorts usually describe MOGCT as a group, and therefore, drawing specific conclusions regarding dysgerminomas is challenging.
Lior, Friedrich   +3 more
openaire   +3 more sources

Frequent expression of CD45RO memory T cell marker as well as low to high expression of PD-1 and PD-L1 inhibitory molecules in seminoma and dysgerminoma.

Journal of Reproductive Immunology, 2023
BACKGROUND Seminoma and dysgerminoma are rare testicular and ovarian germ cell tumors characterized by a significant infiltration of immune cells in the tumor microenvironment.
Hadiseh Farahani   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy